4 Lui Paster
Tel Aviv-Jaffa 6803605
Israel
972 5 2775 5072
https://www.raphaelpharmaceutical.com
Sector(es): Healthcare
Industria: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo:
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Shlomo Pilo | CEO & Chairman | 244k | N/D | 1955 |
Mr. Guy Ofir | CFO & Director | 144k | N/D | 1973 |
Dr. Igal Louria Hayon | CTO & Director | N/D | N/D | 1973 |
Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company develops product candidate for the treatment of rheumatoid arthritis and hyper inflammatory syndrome inflammation related to COVID-19. It also intends to develop product candidate to treat oncology indications. The company is headquartered in Tel Aviv-Jaffa, Israel.
La calificación ISS Governance QuickScore de Raphael Pharmaceutical Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.